FDA approves first insomnia drug for middle-of-the-night waking followed by difficulty returning to sleep
The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep.
